Status:
UNKNOWN
Renal Function and Hemolysis After Pulsed-field Ablation for Atrial Fibrillation
Lead Sponsor:
Charles University, Czech Republic
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the project is to assess hemolysis and renal function after catheter ablation for atrial fibrillation using pulsed-field energy. Hemolysis will be determined using the concentration of red ...
Detailed Description
Methods The project will include patients with paroxysmal and persistent AF who, according to standard recommended procedures, are indicated for catheter ablation using pulsed-field energy and will si...
Eligibility Criteria
Inclusion
- symptomatic paroxysmal or non-paroxysmal atrial fibrillation
Exclusion
- known hematologic disorders
- disorders associated with increased hemolysis
- known significant hepatic disease
- patient in permanent hemodialysis
Key Trial Info
Start Date :
May 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06198933
Start Date
May 1 2024
End Date
December 30 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiocenter, 3rd Medical School, Charles University and University Hospital Kralovske Vinohrady
Prague, Czechia, 10034